Valproate and lamotrigine in pediatric patients with refractory epilepsy: After the first year

Pediatric Neurology

Volumn 48, Issue 6, 2013, Pages 436-442

  Thome Souza, Sigride ^a   Valente, Kette D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; TIME FACTORS; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 84877718476     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2013.01.005     Document Type: Article

References (37)

1. S. Thomé-Souza, A. Freitas, L.A. Fiore, and K.D. Valente Lamotrigine and valproate: Efficacy of co-administration in a pediatric population Ped Neurol 28 2003 360 364
2. V.H. Machado, A. Palmini, F.A. Bastos, and R. Rotert Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: A 'proof of concept,' open label study Epilepsia 52 2011 1303 1310
3. S. Thome-Souza, and K.D. Valente Valproate and lamotrigine in children and adolescents with drop attacks: Follow-up after the first year Epilepsia 52 2011 2139
4. C.D. Ferrie, R.O. Robinson, C. Knott, and C.P. Panayiotopoulos Lamotrigine as an add-on drug in typical absence seizures Acta Neurol Scand 91 1995 200 202
5. P.H. McCabe, N.C. Michel, and C.D. McNew Clinical efficacy of combination therapy with valproic acid and lamotrigine in intractable epilepsy: High success rate with low incidence of rash Epilepsia 39 1998 49
6. P.H. McCabe, C.D. McNew, and N.C. Michel Effect of divalproex-lamotrigine combination therapy in frontal lobe seizures Arch Neurol 58 2001 1264 1268
7. A.P. Aldenkamp, J. Arends, and H.P. Bootsma Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers Epilepsia 43 2002 19 26
8. I.C. Wong, G.E. Mawer, J.W. Sander, and S.D. Lhatoo A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy Epilepsia 42 2001 1354 1358
9. V. Biton, W. Mirza, G. Montouris, A. Vuong, A.E. Hammer, and P.S. Barrett Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy Neurology 23 56 2001 172 177
10. E. Faught, G. Morris, and M. Jacobson Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group Epilepsia 40 1999 1135 1140
11. E. Perucca Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience CNS Drugs 6 2002 695 714
12. R. Guerrini Valproate as a mainstay of therapy for pediatric epilepsy Paediatr Drugs 8 2006 113 129
13. D. Bentué-Ferrer, O. Tribut, and M.C. Verdier Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Therapeutic drug monitoring of valproate Therapie 65 2010 233 240
14. A.T. Berg, S.F. Berkovic, and M.J. Brodie Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009 Epilepsia 51 2010 676 685
15. C.P. Panayiotopoulos The new ILAE report on terminology and concepts for the organization of epilepsies: Critical review and contribution Epilepsia 53 2012 399 404
16. Glaxo-Wellcome. Lamictal Advisory Board Briefing Document, http://www.accessdata.fda.gov/drugsatfda-docs/nda/98/020764a-admindocs-corres- P3.pdf; 1997 October 23.
17. A.H. Guberman, F.M.C. Besag, and M.J. Brodie Lamotrigine associated rash: Risk/benefit considerations in adults and children Epilepsia 40 1999 985 991
18. M. Duchowny, J.M. Pellock, and W.D. Graf A placebo controlled trial of lamotrigine add-on therapy for partial seizures in children Neurology 53 1999 1724 1731
19. C.B. Aiken, and C. Orr Rechallenge with lamotrigine after a rash: A prospective case series and review of the literature Psychiatry 7 2010 27 32
20. M.J. Brodie Lamotrigine: An update Can J Neurol Sci 23 1996 S6 S9
21. F. Pisani, G. Oteri, M.F. Russo, R. Di Perri, E. Perucca, and A. Richens The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction Epilepsia 40 1999 1141 1146
22. A.G. Marson, J.L. Hutton, and J.P. Leach Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review Epilepsy Res 46 2001 259 270
23. P.H. McCabe New anti-epileptic drugs for the 21st century Expert Opin Pharmacother 1 2000 633 674
24. M.J. Brodie, and A.W.C. Yuen Lamotrigine substitution study: Evidence for synergism with sodium valproate 105 Group Study Epilepsy Res 26 1997 423 432
25. J.A. Messenheimer, L. Giorgi, and M.E. Risner The tolerability of lamotrigine in children Drug Safety 22 2000 303 312
26. S. Thome-Souza, B. Moreira, and K. Valente Late adverse effects of the coadministration of valproate and lamotrigine Ped Neurol 47 2012 47 50
27. F. Matsuo Lamotrigine Epilepsia 40 1999 S30 S36
28. Y.J. Cho, K. Heo, and W.J. Kim Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: An observational study Epilepsia 50 2009 1910 1919
29. L. Cocito, M. Maffini, and C. Loeb Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy Epilepsy Res 19 1994 123 127
30. A.M. Kanner, and M. Frey Adding valproate to lamotrigine: A study of their pharmacokinetic interaction Neurology 55 2000 588 591
31. S. Ramaratam, A.G. Marson, and G.A. Baker Lamotrigine add-on for drug-resistant epilepsy Cochrane Database Syst Rev 3 2000 CD001909
32. F.M.C. Besag, S.J. Wallace, O. Dulac, J. Alving, S.C. Spencer, and G. Hosking Lamotrigine for treatment of epilepsy in childhood J Pediatr 127 1995 991 997
33. M.S. Perry, C. Swint, and J. Hawley Caregiver measures for seizure control, efficacy, and tolerability of antiepileptic drugs for childhood epilepsy: results of a preference survey Epilepsy Behav 22 2011 542 547
34. D.W. Loring, D.J. Williamson, K.J. Meador, F. Wiegand, and J. Hulihan Topiramate dose effects on cognition: a randomized double-blind study Neurology 76 2011 131 137
35. H.W. Lee, D.K. Jung, C.K. Suh, S.H. Kwon, and S.P. Park Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up Epilepsy Behav 8 2006 736 741
36. K.P. Grisotto, I. Bruck, S.A. Antoniuk, and L.H. Santos Association of lamotrigine and valproate in refractory epilepsies of children and adolescents Arq Neuropsiquiatr 66 2008 477 481
37. D.C. Reutens, J.S. Duncan, and P.N. Patsalos Disabling tremor after lamotrigine with sodium valproate Lancet 17 1993 185 186